Drugs

Article	Citations
Acknowledgement to Referees	503
Comment on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study”	322
Targeting DNA Damage Response Deficiency in Thoracic Cancers	285
Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema	270
Correction: New Pharmacologic Approaches to the Treatment of Bipolar Depression	232
Correction: Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments	206
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences	177
Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer’s Disease Using	174
Eftrenonacog Alfa: A Review in Haemophilia B	171
Spesolimab for the Treatment of Generalized Pustular Psoriasis	158
Authors’ Reply to Toda: Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations	154
Aztreonam-Avibactam: A Review in the Treatment of Serious Bacterial Infections Caused by Aerobic Gram-Negative Organisms	149
Senaparib: First Approval	142
New Therapies on the Horizon for Primary Biliary Cholangitis	135
Vorasidenib: First Approval	131
Aprocitentan: First Approval	114
Teclistamab: First Approval	111
Epcoritamab: First Approval	108
Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer’s Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled,	107
Efficacy and Safety of Plecanatide in Chinese Patients with Functional Constipation: A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial	99
Alcohol-Associated Liver Disease: Evolving Concepts and Treatments	99
Drugs in Development to Manage Acute Pain	97
Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure	96
Tolebrutinib: First Approval	95
Advances in Pharmacotherapy for Menopausal Vasomotor Symptoms	92

Efficacy and Harms of Opioid Analgesics for Acute Pain: Overview of Systematic Reviews and Meta-analyses	92
Danicopan: First Approval	91
Safety of Anti-osteoarthritis Medications: A Systematic Literature Review of Post-marketing Surveillance Studies	86
Repotrectinib: First Approval	86
Efficacy and Safety of CDK4/6 Inhibitors: A Focus on HR+/HER2− Early Breast Cancer	84
Acoltremon: First Approval	83
QT Prolongation and Risk of Death with the Use of Methadone for Chronic Cancer and Noncancer Pain: Myths or Reality?	82
Cosibelimab: First Approval	81
Androgenetic Alopecia: Therapy Update	79
Lenacapavir: First Approval	79
Ivarmacitinib Sulfate: First Approval	78
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine	74
Cancer Pain Treatment Strategies in Patients with Cancer	72
Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids	72
Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?	70
Sibeprenlimab: First Approval	69
Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?	69
Mazdutide: First Approval	68
Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians	66
Delgocitinib 20 mg/g Cream: A Review in Chronic Hand Eczema	65
Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification	65
SER-109 (VOWST™): A Review in the Prevention of Recurrent Clostridioides difficile Infection	63
Drugs Targeting Cough Receptors: New Therapeutic Options in Refractory or Unexplained Chronic Cough	62
Pozelimab: First Approval	61
Correction to: Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes	60
Correction to: Tapinarof Cream 1%: First Approval	60
Situational Prevention of Migraine Attacks: Can Early Treatment Change the Conversation?	59
Taletrectinib: First Approval	57
Ifupinostat: First Approval	55
Correction to: Prevention and Treatment of Monkeypox	53
The Place of Cannabinoids in the Treatment of Gynecological Pain	52
Sunvozertinib: First Approval	51
Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews	51
Managing Burning Mouth Syndrome: Current and Future Directions	50
Comparative Efficacy of Non-opioid Analgesic Drugs for Chronic Cancer Pain: A Bayesian Network Meta-analysis	50
Pixavir Marboxil: First Approval	50
Aligning Large Language Models with Humans: A Comprehensive Survey of ChatGPT’s Aptitude in Pharmacology	50
Targeting Interferon Signalling in Systemic Lupus Erythematosus: Lessons Learned	49
Targeting Inflammation in Bronchiectasis	48
Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options	48
Pharmacological Treatments of Temporomandibular Disorders: A Systematic Review Including a Network Meta-Analysis	47
Tovorafenib: First Approval	47
Dorzagliatin: First Approval	46
Correction to: Concizumab: First Approval	46
Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades	45
Correction: From Prospective Evaluation to Practice: Model-Informed Dose Optimization in Oncology	44
Correction to: Remdesivir: A Review in COVID-19	44
Pharmacological Management of Obesity in Pregnancy: A Review of Current and Emerging Therapies	44
Focus on Metformin: Its Role and Safety in Pregnancy and Beyond	43
The Utilization of the Accelerated Approval Pathway in Oncology: A Case Study of Pembrolizumab	43

Advances in Immune-Based Approaches for the Cure of HIV Infection	43
Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials	43
Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study	43
Pan-JAK Inhibition Across Chronic Hand Eczema and Other Cutaneous Diseases: An Updated Review on Topical Delgocitinib	42
Birch Bark Extract: A Review in Epidermolysis Bullosa	42
Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review	42
Paracetamol Combination Therapy for Back Pain and Osteoarthritis: A Systematic Review and Meta-Analyses	42
Ozoralizumab: First Approval	42
Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?	41
Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer’	41
Givinostat: First Approval	40
Gepirone Extended-Release: First Approval	39
Catumaxomab: First Approval	39
Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies	38
Tirzepatide: A Review in Type 2 Diabetes	38
Fezolinetant: First Approval	38
Current and Emerging Treatments for Acid Sphingomyelinase Deficiency	37
Polidocanol in Sclerotherapy for Lymphovenous Disorders: Mechanisms, Clinical Uses, and Future Prospects	37
Correction: Ifupinostat: First Approval	37
Becotatug Vedotin: First Approval	37
Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale	36
Ensitrelvir Fumaric Acid: First Approval	36
Futibatinib: First Approval	36
Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy	36
Relacorilant: First Approval	35
Antifungal Treatment Regimens as Primary Therapy for Invasive Aspergillosis: A Systematic Review and Network Meta-analysis	35
Omalizumab in Severe Asthma: Effect on Oral Corticosteroid Exposure and Remodeling. A Randomized Open-Label Parallel Study	34
Update on Mpox Management: Epidemiology, Vaccines and Therapeutics, and Regulatory Changes	34
Correction: Teprotumumab: A Review in Thyroid Eye Disease	34
Correction: Iptacopan: First Approval	34
Avacincaptad Pegol: First Approval	34
Mitapivat: A Review in Pyruvate Kinase Deficiency in Adults	34
Atrasentan: First Approval	34
Effectiveness of Interventions to Reduce Opioid Use After Orthopaedic Surgery: A Systematic Review of Randomised Controlled Trials	33
Beremagene Geperpavec: First Approval	33
Zeprumetostat: First Approval	33
Advanced-Stage Chronic Myeloid Leukemia: Options for Difficult Treatment Situations	33
Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects?	33
Managing Pain in Fibromyalgia: Current and Future Options	33
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease	32
Oral Gut-Restricted Targeted Therapy for IBD: A Pipeline Review	32
Eye Involvement and Management in Inherited Epidermolysis Bullosa	32
Imetelstat: First Approval	31
Correction: Lumasiran: A Review in Primary Hyperoxaluria Type 1	31
Varenicline Solution Nasal Spray: A Review in Dry Eye Disease	31
Lotilaner Ophthalmic Solution 0.25%: First Approval	31
Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases	31
Zastaprazan: First Approval	31
Acknowledgement to Referees	30
Nogapendekin alfa Inbakicept: First Approval	30
Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry	30
Etripamil: First Approval	29
Sepiapterin: First Approval	29
Targeting the Sphingosine-1-Phosphate Pathway: New Opportunities in Inflammatory Bowel Disease Management	29
Crinecerfont: First Approval	29
EGFR Exon 20 Insertion–Mutated Non-Small Cell Lung Cancer: Current Treatment Landscape and Future Directions	29
Revolutionary Changes in the Management of Lupus Nephritis: Towards De-Glucocorticoid or No-Glucocorticoid	29
Efficiency and Safety of Noninvasive and Intravesical Therapy for Adult Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials	28
Retifanlimab: First Approval	28
Botulinum Toxin-A for the Treatment of Myogenous Temporomandibular Disorders: An Umbrella Review of Systematic Reviews	28
Diagnosis and Treatment of AL Amyloidosis	28
Rovadicitinib: First Approval	28
Revumenib: First Approval	28
Mavorixafor: First Approval	27
Tradipitant: First Approval	27
Correction to: Sparsentan: First Approval	27
Comment on: “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study”	27
Direct-Acting Antivirals and the Risk of Arrhythmias and Conduction Disorders in Patients with Chronic Hepatitis C: A French Nationwide Cohort Study	27
Correction: Zastaprazan: First Approval	27
Immune Mechanisms in Epileptogenesis: Update on Diagnosis and Treatment of Autoimmune Epilepsy Syndromes	27
Correction to: Spesolimab: First Approval	27
Methadone for Cancer Pain Management in Children: A Review of Literature	27
Ravulizumab: A Review in Generalised Myasthenia Gravis	26
Efficacy and Safety of Sovateltide in Patients with Acute Cerebral Ischaemic Stroke: A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Phase III Clinical Trial	26
Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer	25
Keverprazan Hydrochloride: First Approval	25
Remdesivir: A Review in COVID-19	25
Onradivir: First Approval	25
Moderate-Intensity Statin Plus Ezetimibe: Time to Rethink it as an Optimal Initial Lipid-Lowering Strategy	25
Zolbetuximab: First Approval	25

Gabapentinoids for Pain: A Review of Published Comparative Effectiveness Trials and Data Submitted to the FDA for Approval

25